http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2484464-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71531ab580ad33a4c335530b2b1f8ef9 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate | 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d83c2c60b390f36e29aad98c27c3045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e2588fc11f46dc43e7bb609cbe8c1ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1983fc6c8b3b3da1add89f8d19e36f5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37ae96aee7202e78c7fc8139678aed7a |
publicationDate | 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2484464-C1 |
titleOfInvention | Method for evaluating clinical effectiveness in vitiligo |
abstract | FIELD: medicine. n SUBSTANCE: exudation cells of a skin window are counted. The neutrophil percentage and the macrophage percentage are assessed, and a coefficient K is determined by formula: К = N ( % ) М ( % ) , n wherein N is a relative neutrophil count in the skin window exudation (%), M is a relative macrophage count (%). A positive response to treatment is stated if observing 10 ≥ K ≥ 1.5. n EFFECT: use of this method enables evaluating the correct therapeutic approach and monitoring the clinical effectiveness before the re-pigmentation signs occur. n 1 tbl, 3 ex |
priorityDate | 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.